1 BACKGROUNDON DECEMBER 8, 1997, HCMF SOLD ITS INSTITUTIONAL PHARMACY, HMI TO PHARMERICA UNDER CIRCUMSTANCES THAT WE BELIEVE IMPLICATE THE FEDERAL ANTI-KICKBACK STATUTE.THE DEPARTMENT OF JUSTICE REFERRED THAT CASE TO THE OIG IN ORDER TO DETERMINE WHETHER THE SALE OF HCMF'S INSTITUTIONAL PHARMACY BUSINESS TO PHARMERICA VIOLATES THE FEDERAL ANTI-KICKBACK STATUE. STATEMENT OF WORKREVIEW, ANALYZE, CONDUCT RESEARCH ON A VARIETY OF FINACIAL INFORMATION REQARDING HCMF'S SALE OF ITS INSTITUTIONAL PHARMACY BUSINESS (HMI) TO PHARMERICA; MEET WITH OCIG ATTORNEYS AND DEFENSE ATTORNEYS TODISCUSS ISSUES RAISED BY THE CASE; RENDER EXPERT OPINIONS REGARDING THE VALUATION OF HMI; AND PERFORM ANY OTHER ANALYSES AS REQUESTED BY OCIG ATTORNEYS THAT MAY BE REQUIRED IN ORDER TO DERIVE A PRELIMINARY OPINION.OBJECTIVETHE GOAL OF RETAINING A LONG TERM CONSULTANCT ARE AS FOLLOWS:1. TO REVIEW, ANALYZE, RESEARCH AND OPINE ON APPROPRATE FINANCIAL INFORMATION IN THE SALE OF HCMF'S INSTITUTIONAL PHARMACY BUSINESS TO PHARMERICA.2. TO PREPARE ROUTINE REPORTS REGARDNG THE TRANSACTION, AS WELL AS RESEARCH THE INDUSTRY-SPECIFIC ISSUES.3. TO CONSLT WITH OCIG TO INTERPRET THE ABOVE DATA AND REPORTS AND ASSIST THE OCIG IN THE PREPARATION OF A WRITTEN EXPERT REPORT, APPREARING AT DEPOSITIONS OR TRIAL, OR PREPARING FOR OR PERTICIPATING IN SETTLEMENT NEGOTIATIONS. Funding Only Action $18.0k 4/1/05 Not listed BACKGROUNDON DECEMBER 8, 1997, HCMF SOLD ITS INSTITUTIONAL PHARMACY, HMI TO PHARMERICA UNDER CIRCUMSTANCES THAT WE BELIEVE IMPLICATE THE FEDERAL ANTI-KICKBACK STATUTE.THE DEPARTMENT OF JUSTICE REFERRED THAT CASE TO THE OIG IN ORDER TO DETERMINE WHETHER THE SALE OF HCMF'S INSTITUTIONAL PHARMACY BUSINESS TO PHARMERICA VIOLATES THE FEDERAL ANTI-KICKBACK STATUE. STATEMENT OF WORKREVIEW, ANALYZE, CONDUCT RESEARCH ON A VARIETY OF FINACIAL INFORMATION REQARDING HCMF'S SALE OF ITS INSTITUTIONAL PHARMACY BUSINESS (HMI) TO PHARMERICA; MEET WITH OCIG ATTORNEYS AND DEFENSE ATTORNEYS TODISCUSS ISSUES RAISED BY THE CASE; RENDER EXPERT OPINIONS REGARDING THE VALUATION OF HMI; AND PERFORM ANY OTHER ANALYSES AS REQUESTED BY OCIG ATTORNEYS THAT MAY BE REQUIRED IN ORDER TO DERIVE A PRELIMINARY OPINION.OBJECTIVETHE GOAL OF RETAINING A LONG TERM CONSULTANCT ARE AS FOLLOWS:1. TO REVIEW, ANALYZE, RESEARCH AND OPINE ON APPROPRATE FINANCIAL INFORMATION IN THE SALE OF HCMF'S INSTITUTIONAL PHARMACY BUSINESS TO PHARMERICA.2. TO PREPARE ROUTINE REPORTS REGARDNG THE TRANSACTION, AS WELL AS RESEARCH THE INDUSTRY-SPECIFIC ISSUES.3. TO CONSLT WITH OCIG TO INTERPRET THE ABOVE DATA AND REPORTS AND ASSIST THE OCIG IN THE PREPARATION OF A WRITTEN EXPERT REPORT, APPREARING AT DEPOSITIONS OR TRIAL, OR PREPARING FOR OR PERTICIPATING IN SETTLEMENT NEGOTIATIONS. Not listed $0 4/1/05